Abstract
Coronavirus disease 2019 (COVID-19) has been tied to many complications
such as hypercoagulability. It is more commonly seen in patients
admitted to intensive care unit. Herein, we report a case of an end
stage renal disease patient who developed recurrent arteriovenous graft
thrombosis in the setting of COVID-19.